Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer
- PMID: 33907439
- PMCID: PMC8071089
- DOI: 10.2147/JIR.S302435
Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer
Abstract
Background: Recent studies have found that clinicopathological indices, such as inflammatory and biochemical indices, play a significant role in the prognosis of colorectal cancer (CRC) patients. However, few studies have focused on the effect of dynamic changes in these indicators. In our study, we studied the influence of dynamic changes in inflammatory and biochemical indices on patient outcomes during the perioperative period.
Methods: We enrolled 551 patients from Hubei Cancer Hospital who had undergone radical resection of CRC and collected the results of laboratory examinations performed within 1 week before surgery and at the first admission after surgery. The whole population was randomly divided into the training (386) and testing (185) cohorts. We used postoperative inflammatory and biochemical indices/preoperative inflammatory and biochemical indices (ΔX) to reflect the dynamic changes. Chi-square tests, Kaplan-Meier survival analyses, and univariate and multivariate Cox regression analyses were used to evaluate the prognosis. The prediction accuracies of models for overall survival (OS) and disease-free survival (DFS) were estimated through Harrell's concordance index (the C-index) and Brier scores. Nomograms of the prognostic models were plotted for evaluations of individualized outcomes.
Results: The median follow-up time of the 551 patients was 35.6 (range: 1.1-73.8) months. Ultimately, the prognostic models based on age, sex, TNM stage, pathological conditions, inflammatory and biochemical indices, CEA, and CA199 were found to have exceptional performance for OS and DFS. The C-index of the nomogram for OS was 0.806 (95% CI, 0.75-0.86) in the training cohort and 0.921 (95% CI, 0.87-0.96) in the testing cohort. The C-index of the nomogram for DFS was 0.781 (95% CI, 0.74-0.82) in the training cohort and 0.835 (95% CI, 0.78-0.88) in the testing cohort.
Conclusion: We successfully established a novel model based on inflammatory and biochemical indices to guide clinical decision-making for CRC.
Keywords: biochemical indices; colorectal cancer; inflammatory indices; nomogram; prognosis; time-dependent receiver operating characteristic curve.
© 2021 Ma et al.
Conflict of interest statement
The authors report no conflicts of interest related to this work.
Figures






Similar articles
-
Creation of a Novel Nomogram Based on the Direct Bilirubin-To-Indirect Bilirubin Ratio and Lactate Dehydrogenase Levels in Resectable Colorectal Cancer.Front Mol Biosci. 2021 Oct 20;8:751506. doi: 10.3389/fmolb.2021.751506. eCollection 2021. Front Mol Biosci. 2021. PMID: 34746234 Free PMC article.
-
Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer.Front Oncol. 2020 Oct 29;10:571169. doi: 10.3389/fonc.2020.571169. eCollection 2020. Front Oncol. 2020. PMID: 33194667 Free PMC article.
-
Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.Front Oncol. 2021 Dec 3;11:776997. doi: 10.3389/fonc.2021.776997. eCollection 2021. Front Oncol. 2021. PMID: 34926285 Free PMC article.
-
Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.Int J Cancer. 2016 Jul 1;139(1):220-31. doi: 10.1002/ijc.30071. Epub 2016 Mar 18. Int J Cancer. 2016. PMID: 26933932
-
What Evidence is There for Biochemical Testing?EJIFCC. 2003 Dec 2;14(3):141-151. eCollection 2003 Dec. EJIFCC. 2003. PMID: 30275815 Free PMC article. Review. No abstract available.
Cited by
-
A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.J Inflamm Res. 2022 May 22;15:3021-3037. doi: 10.2147/JIR.S362166. eCollection 2022. J Inflamm Res. 2022. PMID: 35645577 Free PMC article.
-
Prognostic prediction model of colorectal cancer based on preoperative serum tumor markers.World J Gastrointest Surg. 2024 May 27;16(5):1344-1353. doi: 10.4240/wjgs.v16.i5.1344. World J Gastrointest Surg. 2024. PMID: 38817280 Free PMC article.
-
Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.BMC Med. 2023 Feb 21;21(1):63. doi: 10.1186/s12916-023-02773-2. BMC Med. 2023. PMID: 36803500 Free PMC article.
-
Predictive Nomogram for the Prediction of Early Recurrence of Colorectal Cancer.Int J Gen Med. 2021 Aug 26;14:4857-4866. doi: 10.2147/IJGM.S321171. eCollection 2021. Int J Gen Med. 2021. PMID: 34471379 Free PMC article.
-
Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters.J Inflamm Res. 2022 Sep 12;15:5265-5281. doi: 10.2147/JIR.S383742. eCollection 2022. J Inflamm Res. 2022. PMID: 36120183 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources